EJC Paediatric Oncology (Dec 2023)
CHEK2 GERMLINE VARIANTS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT OUTCOMES
- Atte K Lahtinen,
- Jessica Koski,
- Jarmo Ritari,
- Kati Hyvärinen,
- Satu Koskela,
- Jukka Partanen,
- Kim Vettenranta,
- Minna Koskenvuo,
- Riitta Niittyvuopio,
- Urpu Salmenniemi,
- Maija Itälä-Remes,
- Kirsi Jahnukainen,
- Outi Kilpivaara,
- Ulla Wartiovaara- Kautto,
- Maarja Karu
Affiliations
- Atte K Lahtinen
- Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- Jessica Koski
- Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- Jarmo Ritari
- Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland
- Kati Hyvärinen
- Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland
- Satu Koskela
- Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland
- Jukka Partanen
- Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland
- Kim Vettenranta
- New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Minna Koskenvuo
- New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Riitta Niittyvuopio
- Helsinki University Hospital, Comprehensive Cancer Center, Department of Hematology, and University of Helsinki, Helsinki, Finland
- Urpu Salmenniemi
- Helsinki University Hospital, Comprehensive Cancer Center, Department of Hematology, and University of Helsinki, Helsinki, Finland
- Maija Itälä-Remes
- Turku University Hospital, Department of Clinical Hematology and Stem Cell Transplant Unit, and University of Turku, Turku, Finland
- Kirsi Jahnukainen
- New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Outi Kilpivaara
- Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- Ulla Wartiovaara- Kautto
- Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Helsinki University Hospital, Comprehensive Cancer Center, Department of Hematology, and University of Helsinki, Helsinki, Finland. ulla.wartiovaara
- Maarja Karu
- New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Hematology and Oncology, Tallinn Children's Hospital, Tallinn, Estonia
- Journal volume & issue
-
Vol. 2
p. 100058